Aprotinin versus tranexamic acid: the controversy continues
- 1 March 2006
- journal article
- Published by Wiley in Transfusion
- Vol. 46 (3), 319-320
- https://doi.org/10.1111/j.1537-2995.2006.00767.x
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- A propensity score case‐control comparison of aprotinin and tranexamic acid in high‐transfusion‐risk cardiac surgeryTransfusion, 2006
- Randomized controlled trials of aprotinin in cardiac surgery: could clinical equipoise have stopped the bleeding?Clinical Trials, 2005
- Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: A systematic review and meta-analysis of randomized clinical trialsThe Journal of Thoracic and Cardiovascular Surgery, 2004
- Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomesTransfusion, 2004
- Platelet transfusion and cardiac surgery: a cautionary taleTransfusion, 2004
- Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpointsThe Lancet, 1999
- Is ε-Aminocaproic Acid as Effective as Aprotinin in Reducing Bleeding With Cardiac Surgery?Circulation, 1999
- Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control groupStatistics in Medicine, 1998
- Meta-analysis: Principles and proceduresBMJ, 1997
- Problems with using observational databases to compare treatmentsStatistics in Medicine, 1991